SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Natco Pharma informs about details of loss of certificate

14 May 2024 Evaluate
Natco Pharma has informed that they are in process of issuing duplicate share certificates in the following cases in lieu of the originals thereof, stated to have been lost by the respective shareholder: Leela Gajra Kanji Gajra Folio No. 002826.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

1160.65 -13.35 (-1.14%)
11-May-2026 10:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.55
Dr. Reddys Lab 1280.70
Cipla 1342.45
Zydus Lifesciences 935.75
Lupin 2251.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×